Capstone Investment Advisors
IMCR icon

Capstone Investment Advisors’s Immunocore IMCR Stock Holding History

Capstone Investment Advisors’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,200
Closed -$625K – 1820
2025
Q3 		$625K Hold
17,200
– – ﹤0.01% 1250
2025
Q2 		$540K Hold
17,200
– – ﹤0.01% 1116
2025
Q1 		$510K Hold
17,200
– – ﹤0.01% 1074
2024
Q4 		$507K Sell
17,200
-2,195
-11% -$69.4K ﹤0.01% 1313
2024
Q3 		$604K Sell
19,395
-626
-3% -$22.8K ﹤0.01% 1145
2024
Q2 		$679K Buy
20,021
+1,151
+6% +$58.7K ﹤0.01% 1154
2024
Q1 		$1.23M Buy
+18,870
New +$1.29M ﹤0.01% 1024

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Capstone Investment Advisors's IMCR Position: Q4 2025 in Review

Capstone Investment Advisors sold out of Immunocore (IMCR) in Q4 2025, closing a stake of 17,200 shares — an estimated $625K sold.

Capstone Investment Advisors first reported a position in IMCR in Q1 2024 and held it in 7 quarters. The position peaked at $1.23M in Q1 2024. 149 funds tracked by Wall St. Rank hold IMCR as of Q4 2025.

  • Capstone Investment Advisors reported no remaining Immunocore position as of Q4 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 17,200 Immunocore shares in Q4 2025, an estimated $625K.
  • Capstone Investment Advisors first reported a position in Immunocore in Q1 2024 and held it in 7 quarters.
  • Capstone Investment Advisors's Immunocore position peaked at $1.23M in Q1 2024.
  • 149 funds tracked by Wall St. Rank held Immunocore as of Q4 2025.

Based on Capstone Investment Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.